XML 18 R7.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net (loss) income $ (12,415,192) $ 1,425,333
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Unrealized (gain) loss on investment securities, net (152,276) (1,483,871)
Stock-based compensation 7,650,951 113,077
Accretion of investments at amortized cost (U.S Treasury Bills) (446,701) (322,341)
Purchases from sale of investment securities, at fair value (made by our licensed broker dealer) (1,587,500)
Proceeds from sale of investment securities, at fair value (made by our licensed broker dealer) 632,851
Deferred income tax 225,874
Warrants issued as part of an investment banking deal 165,087
Income recognized from warrants received (359,605) (2,645,620)
Depreciation of property and equipment 130,937 88,249
Deferred costs related to revenue (38,781)
Accretion of deferred grant reimbursement (26,252) 25,920
Deferred revenue (20,000)
Change in ROU Asset 170,581 166,957
Change in lease liability (153,329) (97,334)
(Increase) decrease in -    
Grants receivable (264,852) (264,492)
Prepaid expenses and other current assets 34,874 79,418
Clearing deposits (255,222)
Increase (decrease) in -    
Accounts payable 75,477 (19,966)
Payables to non-customers (418,881)
Payables to customers 977,020
Accrued expenses (957,644) (148,664)
Net cash used in operating activities (6,468,895) (3,647,022)
CASH FLOWS FROM INVESTING ACTIVITIES:    
Proceeds of investments securities, at amortized cost (U.S Treasury Bills) 35,825,998 5,107,908
Purchases of investments securities, at amortized cost (U.S Treasury Bills) (15,762,378) (3,499,352)
Deferred grant reimbursement 6,180 (74,295)
Purchases of property and equipment (174,734) (43,691)
Net cash provided by investing activities 19,895,066 1,490,570
CASH FLOWS FROM FINANCING ACTIVITIES:    
Deferred costs of initial public offering (282,175) (405,029)
Net cash used in financing activities (282,175) (405,029)
NET INCREASE (DECREASE) IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH 13,143,996 (2,561,481)
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH - BEGINNING OF PERIOD 7,357,687 4,952,624
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH - END OF PERIOD 20,501,683 2,391,143
Supplemental disclosures of cash flow information:    
Interest
Income taxes
Non-cash investing and financing activities:    
Warrants received as part of an investment banking deal 359,605 2,480,533
Modification of lease - right-of-use asset and lease liability 198,544
Deferred costs of initial public offering $ 152,065